The CHRD-L2 Polyclonal Antibody (PAC019469) is a powerful tool for researchers studying CHRD-L2, a protein involved in cell adhesion and migration. This antibody, derived from rabbits, is highly specific to human samples and has been validated for use in Western blot applications. By binding to the CHRD-L2 protein, this antibody enables precise detection and analysis in a variety of cell types, making it invaluable for studies in cell biology and cancer research.
CHRD-L2 plays a crucial role in regulating cell movement and interaction, making it a promising target for understanding processes such as metastasis and tissue remodeling. Its involvement in these cellular mechanisms suggests its potential relevance in cancer progression and development. By investigating the function of CHRD-L2, researchers can gain insight into novel therapeutic strategies for combating cancer and other related diseases.
The image on the left is immunohistochemistry of paraffin-embedded Human colon cancer tissue using PACO19469(CHRDL2 Antibody) at dilution 1/20, on the right is treated with synthetic peptide. (Original magnification: x200).
Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Human fetal brain tissue, Primary antibody: PACO19469(CHRDL2 Antibody) at dilution 1/600, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 minute.
The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using PACO19469(CHRDL2 Antibody) at dilution 1/20, on the right is treated with synthetic peptide. (Original magnification: x200).
Background:
CHRDL2 (chordin-related protein 2), also known as BNF1 (breast tumor novel factor 1) or CHL2 (chordin-like 2), is a 429 amino acid, protein that belongs to the chordin family of proteins. CHRDL2 contains three VWFC (von Willebrand Factor type C) domains and is predominantly expressed in uterus and moderately expressed in prostate, liver, ovary, heart and testis. Due to alternative splicing events, CHRDL2 exists as five isoforms, namely isoform I, isoform II, isoform VII, isoform VIII and isoform IX. Two of these isoforms are secreted, while the other three localize to the cytoplasm. Functioning as a BMP-binding inhibitor, CHRDL2 directly interacts with BMPs and blocks their binding to BMP receptors, thereby inhibiting BMP activity. In breast, lung and colon tumors, CHRDL2 expression is upregulated, suggesting a possible role in tumorigenesis.
Synonyms:
chordin-like 2
UniProt Protein Function:
CHRDL2: May inhibit BMPs activity by blocking their interaction with their receptors. Has a negative regulator effect on the cartilage formation/regeneration from immature mesenchymal cells, by preventing or reducing the rate of matrix accumulation. Implicated in tumor angiogenesis. May play a role during myoblast and osteoblast differentiation, and maturation. 5 isoforms of the human protein are produced by alternative splicing.Protein type: Secreted, signal peptide; SecretedChromosomal Location of Human Ortholog: 11q14Cellular Component: extracellular space; cytoplasmBiological Process: ossification; cartilage development; cell differentiation; negative regulation of BMP signaling pathway
UniProt Protein Details:
NCBI Summary:
This gene encodes a member of the chordin family of proteins. Chordin family members are secreted proteins that share a cysteine-rich pro-collagen repeat domain and associate with members of the transforming growth factor beta superfamily. In vitro assays demonstrate a direct interaction between the encoded protein and human activin A. This gene is expressed in many tissues including osteoblasts, where it is differentially expressed during differentiation. In addition, its expression is upregulated in human osteoarthritic joint cartilage, suggesting a role in adult cartilage regeneration. [provided by RefSeq, Jan 2015]